The inhibitory effect of anthocyanins on the PI3K/AKT/Mcl-1 axis highlights their potential as therapeutic agents in diseases characterized by excessive cell survival and resistance to apoptosis, such as cancer and chronic inflammatory conditions (67). The gene discussed is MCL1; the disease is cancer.